Weimin (Will) Liu
About Weimin (Will) Liu
Weimin (Will) Liu is the Managing Director of Bio Ventures at BeiGene in Shanghai, China, with over two decades of experience in the pharmaceutical and venture capital sectors.
Current Position at BeiGene
Weimin (Will) Liu is currently the Managing Director of BioVentures at BeiGene in Shanghai, China. In this role, he oversees venture investment strategies and is responsible for spearheading innovative biotechnological advancements. His leadership is pivotal in guiding BeiGene's mission to develop innovative and impactful pharmaceuticals.
Previous Roles in the Pharmaceutical Industry
Weimin Liu has an impressive history of holding senior positions in the pharmaceutical industry. He worked as a Board Member at Structure Therapeutics from 2019 to 2021 and served as a Partner at Eight Roads from 2017 to 2021 in Shanghai, China. Prior to this, he was Head of Worldwide Business Development, Neurosciences, and Head of Asia at GSK from 2015 to 2017. Liu also contributed to Merck Serono's innovation efforts as Head of External Innovation China from 2013 to 2015 in Beijing, China.
Career Beginnings and Senior Scientific Roles
Weimin Liu began his career in the pharmaceutical industry at Shionogi BioResearch (now Synta) as a Senior Scientist from 1997 to 1999. He then joined Boehringer Ingelheim Pharmaceuticals, holding senior positions as a Senior Scientist from 2000 to 2002 and Principal Scientist from 2003 to 2009 in Ridgefield, Connecticut, USA. He later advanced to Director roles at Bayer HealthCare from 2009 to 2013 in Beijing, China, eventually moving to more strategic roles in the industry.
Educational Background
Weimin Liu holds a Ph.D. in Organic Chemistry from the University of Michigan, reflecting his deep expertise in the field. He also earned a B.S. in Chemistry from Nankai University. His academic background laid the foundation for a career marked by significant contributions to pharmaceutical research and development.
Experience in Neuroscience and Innovation
With a robust background in neuroscience, Weimin Liu led global business development in this field at GSK. His role as the Head of Neurosciences emphasized his expertise in developing strategies for neurological innovations. Additionally, his work at Merck Serono as the Head of External Innovation in China underscored his ability to drive strategic initiatives and foster external partnerships aimed at advancing pharmaceutical innovation.